Subgroup analyses by baseline alcohol consumption of 3-year psychotropic and opioid use and healthcare utilization in patients treated for depression
Abstract
This three-year follow-up study on secondary subgroups embedded in a Swedish randomized controlled trial, Regassa, investigated whether hazardous alcohol consumption influences health care utilization and use of psychotropics and opioids among patients with depression who received treatment for depression but no intervention targeting alcohol use. The cohort of 929 patients was divided into patients reporting hazardous and patients reporting non-hazardous alcohol consumption. Three-year follow-up, registry data on primary and specialized care utilization, as well as dispensed psychotropic and opioid medication were added. Differences in prevalence between the groups were analysed using Prevalence Proportion Ratios and differences in the number of consultations were analyzed using Poisson regression. Medication dispenses and defined daily doses (DDD) were analyzed with a two-step model (1) logistic regression presented as odds ratios (OR) (2) negative binomial regression, presented as incidence rate ratios (IRR). Most participants were women and hazardous alcohol use was reported by 22%, predominantly men. Patients reporting hazardous consumption seemed more likely to be prescribed psychotropics despite fewer health care visits, but among users there were no differences between the groups regarding the amount of medication. Over time, there was a tendency they had lower levels of prescribed opioids and less visits for pain diagnosis. Patients with hazardous alcohol consumption and concurrent depression seem to be prescribed psychotropics more often. These findings may be relevant for clinicians in health care settings when assessing patients with depression to also screen for alcohol consumption and pain and offer tailored and effective interventions.
Related
- Healthcare utilization and medical costs among adults with selected psychiatric disorders: a nationwide retrospective cohort study
- Behavioral pathways to hospitalization: physical exercise, social participation, and healthcare utilization in China
- Burden of Non-Communicable Diseases Attributable to Polygenic Risk and Its Association with Healthcare Utilization in Taiwan
- Sickle Cell Disease Care in Jamaica: Enablers and Barriers to Healthcare Access and Hydroxyurea Utilization
- Health-Related Quality of Life, Healthcare Utilization, and Expenditure in US Adults With Myocardial Infarction and Heart Failure: The Medical Expenditure Panel Survey 2019 to 2024
BibTeX
@article{strid2026subgroup,
title = {{Subgroup analyses by baseline alcohol consumption of 3-year psychotropic and opioid use and healthcare utilization in patients treated for depression}},
author = {Catharina Strid and Andreas Lundin and Yvonne Forsell and Agneta Öjehagen},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-76635-1},
url = {https://www.nature.com/articles/s41598-026-76635-1},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Subgroup analyses by baseline alcohol consumption of 3-year psychotropic and opioid use and healthcare utilization in patients treated for depression
AU - Catharina Strid
AU - Andreas Lundin
AU - Yvonne Forsell
AU - Agneta Öjehagen
PY - 2026
DA - 2026/10/23
JO - Scientific Reports
DO - 10.1038/s41598-026-76635-1
UR - https://www.nature.com/articles/s41598-026-76635-1
AB - This three-year follow-up study on secondary subgroups embedded in a Swedish randomized controlled trial, Regassa, investigated whether hazardous alcohol consumption influences health care utilization and use of psychotropics and opioids among patients with depression who received treatment for depression but no intervention targeting alcohol use. The cohort of 929 patients was divided into patients reporting hazardous and patients reporting non-hazardous alcohol consumption. Three-year follow-up, registry data on primary and specialized care utilization, as well as dispensed psychotropic and opioid medication were added. Differences in prevalence between the groups were analysed using Prevalence Proportion Ratios and differences in the number of consultations were analyzed using Poisson regression. Medication dispenses and defined daily doses (DDD) were analyzed with a two-step model (1) logistic regression presented as odds ratios (OR) (2) negative binomial regression, presented as incidence rate ratios (IRR). Most participants were women and hazardous alcohol use was reported by 22%, predominantly men. Patients reporting hazardous consumption seemed more likely to be prescribed psychotropics despite fewer health care visits, but among users there were no differences between the groups regarding the amount of medication. Over time, there was a tendency they had lower levels of prescribed opioids and less visits for pain diagnosis. Patients with hazardous alcohol consumption and concurrent depression seem to be prescribed psychotropics more often. These findings may be relevant for clinicians in health care settings when assessing patients with depression to also screen for alcohol consumption and pain and offer tailored and effective interventions.
SN - 2045-2322
ER -